It’s wildly clear that really smart women trained in highly technical professions are gaining the attention, trust and investment of venture firms.

This week we tracked $38M+ in seed and Series A/B investments to women-founded companies — in AI-enabled fertility, clinically personalized peptides, fetal brain monitoring tech, and a fintech rewards platform.

From a venture perspective, we are spotting a trend where female investors are betting on founders at the intersection of science and AI — challenging them to build their fundability storylines around not just early stage funding, but also credibility, proof of concept, momentum, and established demand.

Scroll on to browse this week’s Capital Signals, Founders Amplified, and investor Quote of the Week from Rachel Schow of RARE Capital.

The signals in this digest come from a variety of credible sources. If you have a tip, opp, data point, or story you would like to include, please send it to [email protected].

Thank you for being a valued subscriber of WINS LIST.

Amie

The biggest stories about women and capital this week

ONTO Health raises $20M Series A to expand AI-enabled fertility and longevity platform

ONTO Health (Dr. Roohi Jeelani) has raised a $20 million Series A co-led by ARTIS and Humania to scale its AI-enabled, physician-led fertility and longevity care platform. The company plans to expand clinical operations in the U.S. and enter the Gulf region, positioning fertility care within a broader lifecycle health model supported by diagnostics, automation, and longevity science. — Femtech Insider, April 16, 2026

Protocole launches with $6M to build clinical peptide platform for longevity and metabolic health

Protocole (Delphine Le Grand and Cindy Yan) has raised $6 million in seed funding led by Rare Capital (Rachel Schow) to develop a clinical platform delivering personalized peptide protocols for longevity, performance, and metabolic health. The company connects users with licensed clinicians and regulated pharmacies, aiming to formalize a rapidly growing but historically unregulated peptide market as the FDA moves to reclassify key compounds— Fitt, April 14, 2026 (Ryan Deer)

Wavelet Medical raises $7M seed to develop non-invasive fetal brain monitoring platform

Wavelet Medical (Liz Golden, Dr. Emily Lee) has raised $7 million in seed funding through a partnership with Aegis Ventures to develop an AI-powered, non-invasive fetal EEG platform for real-time brain monitoring during labor. The company is targeting a critical gap in maternal care, where current monitoring methods are inconclusive in up to 85% of births, contributing to over 35,000 infant brain injuries annually in the U.S. — Femtech Insider, April 14, 2026

Debbie raises $5.3M seed to build fintech rewards platform for saving and debt reduction

Debbie (Frida Leibowitz and Rachel Lauren) has raised a $5.3 million seed round led by TruStage Ventures and Reseda Group, with participation from One Way Ventures and Zeal Capital Partners, bringing total funding to approximately $8 million. The company is building a fintech platform that rewards users for saving and paying down debt, positioning itself against a U.S. credit card market where balances exceed $1.27 trillion. — StartupBeat, April 13, 2026 (StartupBeat Team)

Emmeline Ventures and Portfolia back $8M investment in FDA-cleared Osteoboost Health, bone health wearable for women

Emmeline Ventures (La Keisha Landrum Pierre and Azin Radsan van Alebeek) and Portfolia (Trish Costello) participated in an $8 million financing round for Osteoboost Health, alongside Ambit Health Ventures, Disrupt Health Impact Fund, and Esplanade Ventures. The round supports scaling a prescription wearable that uses vibration therapy to slow bone loss in postmenopausal women, addressing a major unmet need where no FDA-approved drug therapies currently exist for osteopenia. — Athletech News, April 20, 2026 (Courtney Rehfeldt)

Revaia leads $40M Series B investment into Synera, doubling down on agentic AI infrastructure

Revaia (Alice Albizzati and Elina Berrebi) led a $40 million Series B investment into Synera. The round brings total funding in Synera to approximately $58 million, supporting its expansion of agentic AI systems embedded in engineering workflows across enterprise customers like NASA, BMW, and Airbus. — The Next Web, April 14, 2026 (Ana-Maria Stanciuc)

High-signal woman founders building momentum

The Win: Wavelet Medical brings capital + category validation to fetal brain monitoring

Signal Breakdown:

In this week’s announcement, Wavelet isn’t just talking about funding. The founders (Liz Golden, Jose Cortes-Briones, Ph.D. and Dr. Emily Lee) are building their fundability story by showcasing:

✅ Capital validation: $7M seed round + Aegis Ventures partnership signals strong early institutional backing beyond just financing.

✅ Category creation momentum: Wavelet is bringing AI into fetal brain signal detection.

✅ Clinical traction: Active pilots across Yale, LA General, and Yonsei with roughly 300 patients enrolled.

✅ High-credibility founding team: Founders have deep clinical + AI research expertise.

They are not just on the path to innovation that leverages AI + science to better understand the human brain before birth; they’re also saving lives.

Notable commentary from women in venture capital

Adjacent to her firm’s $6M seed investment in Protocole…

That’s a wrap on issue #05.

WINS LIST tracks the signals shaping venture outcomes for women founders.

We are not just following the top stories. We are trend spotting and amplifying founders who showcase credibility, capability, market, proof, and momentum.

We are unboxing investor perspectives and framing out the fundability metrics they evaluate when considering not only where their investments should go, but also which founders to meet.

We do not represent nor are we compensated by any of the businesses we cover.

Thank you for being a valued subscriber.

See you next Tuesday.

— WINS LIST